Victoria L Haller
Overview
Explore the profile of Victoria L Haller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
145
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haller V, Stevens D, Welch S
Eur J Pharmacol
. 2008 Sep;
600(1-3):50-8.
PMID: 18762181
Lack of involvement of the opioid system with the endocannabinoid, arachidonylethanolamide (anandamide) was possibly due to hydrolysis by fatty acid amide hydrolase (FAAH). Cyclohexylcarbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597) is an...
2.
Williams J, Haller V, Stevens D, Welch S
Eur J Pharmacol
. 2008 Mar;
584(1):78-86.
PMID: 18313663
We have previously demonstrated synergy between morphine and Delta(9)-tetrahydrocannabinol (Delta(9)-THC) in the expression of antinociception in acute pain models and in arthritic models of chronic pain. Our data has been...
3.
Kren M, Haller V, Welch S
Eur J Pharmacol
. 2007 Dec;
578(2-3):177-84.
PMID: 18054782
The purpose of this study was to evaluate the effects of the gonadal hormones on the opioid receptor protein levels of Freund's adjuvant-treated (arthritic) male and female Lewis rats. Following...
4.
Haller V, Bernstein M, Welch S
Eur J Pharmacol
. 2007 Dec;
578(2-3):101-7.
PMID: 18048029
Voltage-gated L- and N-type calcium channels (VOCs) are implicated in the activity of morphine, but their contribution to the expression of opioid tolerance remains uncertain. L- and N-type VOCs are...
5.
Cox M, Haller V, Welch S
Eur J Pharmacol
. 2007 Jun;
570(1-3):50-6.
PMID: 17588560
Cannabinoid CB(2) receptors have been implicated in antinociception in animal models of both acute and chronic pain. We evaluated the role both cannabinoid CB(1) and CB(2) receptors in mechanonociception in...
6.
Cox M, Haller V, Welch S
Eur J Pharmacol
. 2007 May;
567(1-2):125-30.
PMID: 17498686
We have shown in past isobolographic studies that a small amount of Delta(9)-tetrahydrocannabinol (Delta(9)-THC) can enhance morphine antinociception in mice. However, previous studies of the Delta(9)-THC/morphine interaction were performed using...
7.
Haller V, Cichewicz D, Welch S
Eur J Pharmacol
. 2006 Aug;
546(1-3):60-8.
PMID: 16919265
The analgesic and anti-hyperalgesic effects of cannabinoid- and vanilloid-like compounds, plus the fatty acid amide hydrolase (FAAH) inhibitor Cyclohexylcarbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597), and acetaminophen, were evaluated in the phenyl-p-quinone...
8.
Williams I, Edwards S, Rubo A, Haller V, Stevens D, Welch S
Eur J Pharmacol
. 2006 May;
539(1-2):57-63.
PMID: 16687136
Delta9-tetrahydrocannabinol (delta9-THC) synergizes with morphine and codeine by releasing endogenous opioids. These studies determined 1) the duration of enhancement of morphine and codeine by delta9-THC, 2) the effect of (delta9-THC...